<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rodriguez-Calienes A</submitter><funding>NCATS NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>2522-2533</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10599264</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to describe the safety and efficacy of mechanical thrombectomy (MT) with or without intravenous thrombolysis (IVT) for patients with tandem lesions and whether using intraprocedural antiplatelet therapy influences MT's safety with IVT treatment.&lt;h4>Methods&lt;/h4>This is a subanalysis of a pooled, multicenter cohort of patients with acute anterior circulation tandem lesions treated with MT from 16 stroke centers between January 2015 and December 2020. Primary outcomes included symptomatic intracranial hemorrhage (sICH) and parenchymal hematoma type 2. Additional outcomes included hemorrhagic transformation, successful reperfusion (modified Thrombolysis in Cerebral Infarction score 2b-3), complete reperfusion (modified Thrombolysis in Cerebral Infarction score 3), f</pubmed_abstract><journal>Stroke</journal><pubmed_title>Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions.</pubmed_title><pmcid>PMC10599264</pmcid><funding_grant_id>R03 NS126804</funding_grant_id><funding_grant_id>K23 NS110980</funding_grant_id><funding_grant_id>R21 NS130423</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>R01 NS127114</funding_grant_id><funding_grant_id>P20 GM109089</funding_grant_id><pubmed_authors>Rizzo F</pubmed_authors><pubmed_authors>Mokin M</pubmed_authors><pubmed_authors>Malik AM</pubmed_authors><pubmed_authors>Qureshi A</pubmed_authors><pubmed_authors>Ikram A</pubmed_authors><pubmed_authors>Abdalkader M</pubmed_authors><pubmed_authors>Farooqui M</pubmed_authors><pubmed_authors>Siegler JE</pubmed_authors><pubmed_authors>Gordon W</pubmed_authors><pubmed_authors>Sheth S</pubmed_authors><pubmed_authors>Abraham M</pubmed_authors><pubmed_authors>Janjua N</pubmed_authors><pubmed_authors>Hassan AE</pubmed_authors><pubmed_authors>Turabova C</pubmed_authors><pubmed_authors>Nguyen TN</pubmed_authors><pubmed_authors>Yoo AJ</pubmed_authors><pubmed_authors>Quispe-Orozco D</pubmed_authors><pubmed_authors>Vivanco-Suarez J</pubmed_authors><pubmed_authors>Begunova L</pubmed_authors><pubmed_authors>Jumaa MA</pubmed_authors><pubmed_authors>Vigilante N</pubmed_authors><pubmed_authors>Linares G</pubmed_authors><pubmed_authors>Matsouka S</pubmed_authors><pubmed_authors>Petersen NH</pubmed_authors><pubmed_authors>Yavagal DR</pubmed_authors><pubmed_authors>Guerrero WR</pubmed_authors><pubmed_authors>Jovin T</pubmed_authors><pubmed_authors>Salazar-Marioni S</pubmed_authors><pubmed_authors>Ribo M</pubmed_authors><pubmed_authors>Tekle WG</pubmed_authors><pubmed_authors>Rodriguez-Calienes A</pubmed_authors><pubmed_authors>Galecio-Castillo M</pubmed_authors><pubmed_authors>Soomro J</pubmed_authors><pubmed_authors>Ortega-Gutierrez S</pubmed_authors><pubmed_authors>Divani AA</pubmed_authors><pubmed_authors>Fifi J</pubmed_authors><pubmed_authors>Alhajala H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions.</name><description>&lt;h4>Background&lt;/h4>We aimed to describe the safety and efficacy of mechanical thrombectomy (MT) with or without intravenous thrombolysis (IVT) for patients with tandem lesions and whether using intraprocedural antiplatelet therapy influences MT's safety with IVT treatment.&lt;h4>Methods&lt;/h4>This is a subanalysis of a pooled, multicenter cohort of patients with acute anterior circulation tandem lesions treated with MT from 16 stroke centers between January 2015 and December 2020. Primary outcomes included symptomatic intracranial hemorrhage (sICH) and parenchymal hematoma type 2. Additional outcomes included hemorrhagic transformation, successful reperfusion (modified Thrombolysis in Cerebral Infarction score 2b-3), complete reperfusion (modified Thrombolysis in Cerebral Infarction score 3), f</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-06-01T22:15:52.139Z</modification><creation>2025-04-04T00:34:18.318Z</creation></dates><accession>S-EPMC10599264</accession><cross_references><pubmed>37602387</pubmed><doi>10.1161/STROKEAHA.123.042966</doi><doi>10.1161/strokeaha.123.042966</doi></cross_references></HashMap>